Jasdeep Singh

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

Raches Ella, Siddarth Reddy, William C. Blackwelder et al. · The Lancet · 2021 · 358 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications

Jasdeep Singh, Jasmine Samal, Vipul Kumar et al. · Viruses · 2021 · 124 citations · Full text

Possible Link between Higher Transmissibility of Alpha, Kappa and Delta Variants of SARS-CoV-2 and Increased Structural Stability of Its Spike Protein and hACE2 Affinity

Vipul Kumar, Jasdeep Singh, Seyed E. Hasnain et al. · International Journal of Molecular Sciences · 2021 · 90 citations · Full text

Engineering, Immunology, Viral Pathogenesis +20

Polyphenols in combination with β-cyclodextrin can inhibit and disaggregate α-synuclein amyloids under cell mimicking conditions: A promising therapeutic alternative

Saurabh Gautam, Sandip Karmakar, Radhika Batra et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 2017 · 69 citations

Neurodegenerative Diseases, Medicine, Degenerative Pathology +5

Mycobacterium tuberculosis Protein PE6 (Rv0335c), a Novel TLR4 Agonist, Evokes an Inflammatory Response and Modulates the Cell Death Pathways in Macrophages to Enhance Intracellular Survival

Neha Sharma, Mohd Shariq, Neha Quadir et al. · Frontiers in Immunology · 2021 · 68 citations · Full text